Ethical and safety issues of stem cell-based therapy part 23

Stem cell 5

 

Mesenchymal stem cells in inflammatory bowel diseases therapy

Instantly, there are two routes for the administration of mesenchymal stem cells  in inflammatory bowel diseases patients: intravenous administration for the systemic control of intestinal inflammation in the tharapy of luminal Chron’s diseases and ulcerative colitis, and the local administration as a therapeutic approach for patients with perianal fistulazing Chron’s diseases. Administration of autologous or allogeneic mesenchymal stem cells derived from bone marrow and adipose tissue achieved significant clinical efficacy in patients with fistulazing Chron’s disease by attenuating local immune response and by promoting tissue repair.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s